Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells-Reference-Cited by-同舟云学术

Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells

Published:2016-10-27 Issue: Volume:9 Page:
ISSN:1662-5099
Container-title:Frontiers in Molecular Neuroscience
language:
Short-container-title:Front. Mol. Neurosci.

Author:

Angeletti Francesca,Fossati Gianluca,Pattarozzi Alessandra,Würth Roberto,Solari Agnese,Daga Antonio,Masiello Irene,Barbieri Federica,Florio Tullio,Comincini Sergio

Publisher

Frontiers Media SA

Subject

Cellular and Molecular Neuroscience,Molecular Biology

Reference67 articles.

1. Therapeutic implications of cancer stem cells;Al-Hajj;Curr. Opin. Genet. Dev.,2004

2. Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357;Armeanu;J. Hepatol.,2005

3. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility;Bajetto;J. Biol. Regul. Homeost. Agents,2013

4. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma;Banelli;Cell Cycle,2015

5. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses;Bolden;Cell Death Dis.,2013

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells;Journal of Experimental & Clinical Cancer Research;2024-08-10

2. The hidden architects of glioblastoma multiforme: Glioma stem cells;MedComm – Oncology;2024-02

3. Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells;Frontiers in Pharmacology;2023-09-28

4. Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer;Frontiers in Immunology;2023-03-09

5. Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide;Anticancer Research;2023-02-28